(SRI) Stoneridge - Overview
Stock: Sensors, Switches, Actuators, Driver Information, Vision
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 70.0% |
| Relative Tail Risk | -4.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.17 |
| Alpha | 58.31 |
| Character TTM | |
|---|---|
| Beta | 1.986 |
| Beta Downside | 1.923 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.25% |
| CAGR/Max DD | -0.34 |
Description: SRI Stoneridge January 02, 2026
Stoneridge Inc. (NYSE:SRI) designs and manufactures engineered electrical and electronic systems for a broad range of vehicle markets-including automotive, commercial, off-highway, and agricultural-across North America, South America, Europe, Mexico, China, and other international regions. The business is organized into three segments: Control Devices (actuators, sensors, switches, connectors), Electronics (driver-information, vision, connectivity, compliance modules), and Stoneridge Brazil (vehicle-tracking, security, telematics, and driver-information solutions). Its customer base spans OEMs, Tier-1 suppliers, and aftermarket distributors.
Key recent metrics: FY 2023 revenue was approximately $1.3 billion, with an adjusted EBITDA margin near 7 %, reflecting steady demand for advanced driver-assist and telematics platforms. The automotive electronics sector is projected to grow ~5 % CAGR through 2028, driven by the electrification trend and stricter emissions/compliance standards, which directly supports Stoneridge’s “Electronics” segment. Additionally, the company’s exposure to the Brazilian fleet-management market provides a hedge against slower growth in mature North American OEM channels.
For a deeper quantitative view, you may want to explore the SRI valuation metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -32.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.19 > 1.0 |
| NWC/Revenue: 23.37% < 20% (prev 26.59%; Δ -3.23% < -1%) |
| CFO/TA 0.07 > 3% & CFO 44.4m > Net Income -32.0m |
| Net Debt (126.7m) to EBITDA (8.21m): 15.43 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.8m) vs 12m ago 0.57% < -2% |
| Gross Margin: 20.88% > 18% (prev 0.20%; Δ 2068 % > 0.5%) |
| Asset Turnover: 135.1% > 50% (prev 138.8%; Δ -3.72% > 0%) |
| Interest Coverage Ratio: -1.27 > 6 (EBITDA TTM 8.21m / Interest Expense TTM 13.5m) |
Altman Z'' 2.83
| A: 0.32 (Total Current Assets 384.3m - Total Current Liabilities 180.0m) / Total Assets 632.1m |
| B: 0.24 (Retained Earnings 154.1m / Total Assets 632.1m) |
| C: -0.03 (EBIT TTM -17.1m / Avg Total Assets 647.3m) |
| D: 0.09 (Book Value of Equity 33.1m / Total Liabilities 380.9m) |
| Altman-Z'' Score: 2.83 = A |
Beneish M -3.18
| DSRI: 1.02 (Receivables 153.1m/158.5m, Revenue 874.4m/919.5m) |
| GMI: 0.96 (GM 20.88% / 20.06%) |
| AQI: 1.05 (AQ_t 0.21 / AQ_t-1 0.20) |
| SGI: 0.95 (Revenue 874.4m / 919.5m) |
| TATA: -0.12 (NI -32.0m - CFO 44.4m) / TA 632.1m) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of SRI shares?
Over the past week, the price has changed by +28.72%, over one month by +41.40%, over three months by +47.05% and over the past year by +86.56%.
Is SRI a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SRI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | 88.9% |
| Analysts Target Price | 16 | 88.9% |
| ValueRay Target Price | 8.5 | 0.1% |
SRI Fundamental Data Overview February 03, 2026
P/S = 0.2108
P/B = 0.7451
P/EG = 53.46
Revenue TTM = 874.4m USD
EBIT TTM = -17.1m USD
EBITDA TTM = 8.21m USD
Long Term Debt = 170.2m USD (from longTermDebt, last quarter)
Short Term Debt = 947.0k USD (from shortTermDebt, last quarter)
Debt = 180.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 126.7m USD (from netDebt column, last quarter)
Enterprise Value = 311.0m USD (184.4m + Debt 180.7m - CCE 54.0m)
Interest Coverage Ratio = -1.27 (Ebit TTM -17.1m / Interest Expense TTM 13.5m)
EV/FCF = 13.23x (Enterprise Value 311.0m / FCF TTM 23.5m)
FCF Yield = 7.56% (FCF TTM 23.5m / Enterprise Value 311.0m)
FCF Margin = 2.69% (FCF TTM 23.5m / Revenue TTM 874.4m)
Net Margin = -3.66% (Net Income TTM -32.0m / Revenue TTM 874.4m)
Gross Margin = 20.88% ((Revenue TTM 874.4m - Cost of Revenue TTM 691.8m) / Revenue TTM)
Gross Margin QoQ = 21.24% (prev 21.47%)
Tobins Q-Ratio = 0.49 (Enterprise Value 311.0m / Total Assets 632.1m)
Interest Expense / Debt = 2.10% (Interest Expense 3.80m / Debt 180.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -13.5m (EBIT -17.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.13 (Total Current Assets 384.3m / Total Current Liabilities 180.0m)
Debt / Equity = 0.72 (Debt 180.7m / totalStockholderEquity, last quarter 251.2m)
Debt / EBITDA = 15.43 (Net Debt 126.7m / EBITDA 8.21m)
Debt / FCF = 5.39 (Net Debt 126.7m / FCF TTM 23.5m)
Total Stockholder Equity = 252.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.95% (Net Income -32.0m / Total Assets 632.1m)
RoE = -12.69% (Net Income TTM -32.0m / Total Stockholder Equity 252.5m)
RoCE = -4.05% (EBIT -17.1m / Capital Employed (Equity 252.5m + L.T.Debt 170.2m))
RoIC = -3.09% (negative operating profit) (NOPAT -13.5m / Invested Capital 437.6m)
WACC = 7.50% (E(184.4m)/V(365.0m) * Re(13.23%) + D(180.7m)/V(365.0m) * Rd(2.10%) * (1-Tc(0.21)))
Discount Rate = 13.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.60%
[DCF Debug] Terminal Value 72.55% ; FCFF base≈18.2m ; Y1≈11.9m ; Y5≈5.44m
Fair Price DCF = N/A (negative equity: EV 116.8m - Net Debt 126.7m = -9.88m; debt exceeds intrinsic value)
EPS Correlation: -10.23 | EPS CAGR: 44.73% | SUE: -0.11 | # QB: 0
Revenue Correlation: -6.57 | Revenue CAGR: 0.86% | SUE: 0.84 | # QB: 0
EPS next Year (2026-12-31): EPS=0.26 | Chg30d=-0.110 | Revisions Net=-1 | Growth EPS=+161.9% | Growth Revenue=+6.4%